Vδ1+ and Vδ2+ γδ T cells recruited to the TME further exert tumor killing effects through perforin/granzyme-, IFN-γ/TNF-α-, death receptor ligand-, and ADCC pathway-mediated cytotoxicity [27, 34]. The gene discussed is IFNG; the disease is neoplasm.